The history of Sildenafil presents a challenging picture for investors. While the initial launch generated significant gains, the expiration of its exclusive rights opened the floodgates to cheaper competitors, https://myfirstbookmark.com/story21662221/sildenafil-and-pharma-a-precarious-investment